Bullish Case: PRCH ($17.65) is up 44.8% in 90 days with call volume 96% above puts, Helium's +3.67% forecast, and a backwardated term structure (Nov ~79-101% falling to Jan/Feb ~63-87%) showing near-term event risk priced but no escalation. Helium's density peaks at $17.50 and the Allied Trust acquisition ($200M premium, $25M EBITDA) plus Louisiana expansion give fundamental fuel. If Q3 margin/loss-ratio holds, drift through $20 is the path of least resistance.

Bearish Case: After a 44.8% 90-day run, expectations are fragile. Deep-OTM put IV remains extreme (95% on Nov 15P, 140%+ on low strikes), Helium's forecast correlation is only 0.1, and Helium sees wider downside tails than the market. Dilution from acquisition share payments, insider selling, and a loss-ratio disappointment could pull price back toward the $12.50-$15 market-density zone with gap risk.

Potential Outcomes:

1. 35% Range $15.50-$19 through Nov/Dec earnings; falsified by sustained close outside band.
2. 25% Break $20+ if Q3 loss-ratio beats and call-wing IV (Jan'27 35C at 87%) holds; confirmed by close >$19.50.
3. 22% Retreat to $12.50-$15 on acquisition dilution or guidance miss; put IV re-bids.
4. 13% Drop <$10 on liquidity/insurance shock; deep-put IV spike.
5. 5% >$22.50 moon with vol compression.

October 20, 2026